U.S. Department of Health and Human Services
National Institutes of Health
National Center for Advancing Translational Sciences
This article shares the team’s insights on early planning and navigating regulatory requirements for gene therapy development. It highlights the value of a target product profile and INTERACT meeting with the FDA.
Human Gene Therapy | March 6, 2025
